BDRX

Biodexa Pharmaceuticals
BDRX

5 hedge funds and large institutions have $45.8K invested in Biodexa Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$18.2K
2
+$11.2K
3
+$9.81K
4
TSS
Two Sigma Securities
New York
+$2.6K
5
BBA
Baader Bank Aktiengesellschaft
Germany
+$865

Top Sellers

1
-$21K
2
-$18K
3
-$11.9K
4
KWM
Kingsview Wealth Management
Oregon
-$6.49K
5
Morgan Stanley
Morgan Stanley
New York
-$534
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$18.2K
2
$14K
3
$9.81K
4
$2.6K
5
$865
6
$163
7
$94
8
$12
9
–
10
–
11
–
12
–